Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
US7862817B2 · kind B2 · utility
60Cited by
108References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 27, 2005 |
| Grant date | Jan 4, 2011 |
| Priority date | — |
| Expiry date | Jan 17, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/801
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application describes humanized anti-ErbB2 antibodies and methods for treating cancer with anti-ErbB2 antibodies, such as humanized anti-ErbB2 antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.